Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by AREND, L. J.
Right arrow Articles by BRIGGS, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by AREND, L. J.
Right arrow Articles by BRIGGS, J. P.
J Am Soc Nephrol 11:2297-2305, 2000
© 2000 American Society of Nephrology

Mouse ß6 Integrin Sequence, Pattern of Expression, and Role in Kidney Development

LOIS J. AREND*, ANN M. SMART{dagger} and JOSIE P. BRIGGS{dagger}

* Department of Pathology, University of Michigan, Ann Arbor, Michigan
{dagger} National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.

Correspondence to Dr. Lois J. Arend, Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Box 626, Rochester, NY 14642. Phone: 716-273-4062; Fax: 716-756-4468; E-mail: lois_arend{at}urmc.rochester.edu


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Abstract. Integrins mediate cell-cell and cell-extracellular matrix interactions and play key roles in development. ß6 integrin expression has been demonstrated in human fetal kidney at a higher level than in the adult, making ß6 integrin a marker of interest for the study of development of the nephron. The aims of this study were to determine the cDNA sequence for the mouse ß6 integrin and to characterize ß6 integrin expression in the developing mouse kidney. Two embryonic mouse kidney cDNA libraries were screened, and the coding region was sequenced. The mouse ß6 nucleotide coding region sequence shows 82% nucleotide identity to the human sequence. The putative amino acid sequence has 89.5% identity to human ß6 integrin and contains many conserved domains. By reverse transcription-PCR, ß6 integrin mRNA expression is very low at 11 d of gestation in the mouse, increases dramatically by E14 and E17 (20-fold, normalized for increases in ß actin), and plateaus by 2 wk of age. ß6 integrin expression is induced 15- to 20-fold after 5 d in metanephric explant culture. Reverse transcription-PCR of adult rat microdissected nephron segments demonstrates ß6 integrin mRNA expression in proximal tubule, cortical thick ascending limb, distal nephron segments (inner and outer medullary collecting ducts), and macula densa—containing segments. Lectin-peroxidase and in situ colocalization studies demonstrated expression of ß6 integrin mRNA in developing proximal tubules and thick ascending limb. Culture of mouse metanephric kidneys with antisense oligonucleotides to ß6 integrin resulted in inhibition of ureteric bud branching and complete lack of mesenchyme condensation. These studies demonstrate a high homology between the human and mouse ß6 integrin sequence, a different pattern of expression in the developing mouse kidney compared with the primate kidney, and abnormal metanephric development in culture in the absence of ß6 integrin. These findings suggest an important role for ß6 integrin in normal development of the mouse kidney.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Integrins are integral cell membrane molecules, consisting of {alpha} and ß subunits, that are important in cell—cell and cell—extracellular matrix interactions (1,2). Integrins have important roles in growth and differentiation (3,4,5) and influence various steps in the development of many organs. In the kidney, several integrins have been shown to be involved in metanephric differentiation. Mice with a mutation in the gene for the {alpha}8 integrin have defects in metanephric differentiation with reduced ureteric bud branching and defective epithelialization of mesenchyme cells (6). Mutation of the {alpha}3 subunit, which associates with the ß1 subunit, results in reduced branching of the ureteric bud and alterations in the architecture of developing nephrons (3). The {alpha}v integrin subunit has also been shown to be important in the development of the metanephros in culture (7).

A unique epithelial integrin subtype, the ß6 integrin subunit, has been shown to be expressed in the primate kidney, with greater expression during development than in the adult (8). The ß6 integrin, which is known to combine with the {alpha}v subunit to form a receptor for fibronectin and tenascin (9,10,11), may represent a differentiation marker for the nephron, because this protein begins to be expressed during development of the kidney and declines in expression as the kidney matures (8,12). Expression of ß6 integrin is also increased during periods of inflammation or repair in the kidney, such as in chronic pyelonephritis or transplant rejection (8). ß6 integrin has been shown to be important in regulating the inflammatory response; a knockout model produced mice with significant inflammatory infiltration of their skin and lungs (13). No significant renal abnormality was noted. The sequence of human ß6 integrin is known; however, study of kidney development is best performed in the rat or mouse, where isolation and culture of the metanephros is easily accomplished and where there is a large database of information on kidney development.

The studies described here deduced the cDNA sequence of the mouse homologue of ß6 integrin and examined the expression of ß6 integrin in the developing and adult mouse kidney. The nucleotide and putative peptide sequences show high homology to human. The expression of ß6 integrin in the mouse kidney differs from that in the human; although expression is greater in the developing kidney than in the adult, expression of ß6 integrin in the mouse nephron is much more ubiquitous. In primate tissue, ß6 integrin expression is described as specifically in macula densa (8,12), whereas in the mouse, expression in the macula densa is not identified until the glomerulus is mature. Expression is also found in proximal convoluted tubule (PCT), the loop of Henle, and collecting ducts. Incubation of mouse metanephric kidneys in culture with antisense oligonucleotides against ß6 integrin resulted in dramatic inhibition of branching of the ureteric bud and differentiation of the mesenchyme. These results demonstrate that in the cultured metanephric kidney, ß6 integrin expression is necessary for normal renal development.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals and Dissection
Timed-pregnant mice were obtained from Harlan Sprague Dawley (Indianapolis, IN) and were killed by cervical dislocation at 11.5 d of gestation (day of vaginal plug designated as day 0 of gestation). A midline abdominal incision was made to expose the uterine horns, which were removed aseptically and placed in cold culture medium (Dulbecco's modified Eagle's medium [DMEM], supplemented with 10% fetal calf serum, 2 mM glutamine, 1 µM dexamethasone, and 50 µg/ml each penicillin and streptomycin). Embryos were removed from the placental membranes and placed in cold phosphate-buffered saline (PBS; 8 mM NaH2PO4 H2O, 140 mM NaCl, 3 mM KCl, 1.5 mM KH2PO4 [pH 7.43]) for dissection of the kidneys. Embryonic kidneys were isolated and cultured intact, containing both ureteric bud and mesenchyme, using a modification of the transfilter system developed by Grobstein (14). Kidneys were placed on filters (PC MB, 13 mm, 0.6 um, Costar) sitting atop a metal screen with a central hole, in six-well culture plates. The volume of culture medium was adjusted to soak the bottom of the filter without submerging the tissue. The kidneys were incubated at 37°C with 5% CO2.

Microdissection of Tubules and Glomeruli
Experiments were performed in Sprague-Dawley rats that weighed 175 to 200 g. The rats were anesthetized by intraperitoneal injection of pentobarbital. The left kidney was perfused from the aorta, which was cannulated below the level of the kidneys and ligated proximal to the origin of the left renal artery. After the renal vein was severed, the kidney was perfused with 30 ml of cold saline, followed by perfusion with 30 ml of cold DMEM containing 1 mg/ml collagenase. The kidney was removed, cut into coronal slices, and incubated in DMEM/collagenase at 37°C for 22 min. Slices were rinsed with cold PBS, placed into DMEM containing 1% fetal calf serum, and maintained at 4°C during dissection. Glomeruli were dissected without tubule or vessel attachments. In general, 5 to 20 glomeruli or 5 to 10 mm of tubule length were pooled to constitute one sample. Samples were transferred in 10 µl dissection medium into 100 µl GITC buffer, snap frozen in liquid nitrogen, and stored at -80°C for later RNA extraction and cDNA synthesis.

Determination of mRNA Expression by Reverse Transcription-PCR
To determine ß6 integrin expression in microdissected nephron segments or metanephric kidneys, we snap-froze tissues in guanidine isothiocyanate solution and stored them at -80°C until use. Total RNA was then isolated using a discontinuous gradient of cesium chloride, with Escherichia coli ribosomal RNA as carrier. For RNA isolation from adult mouse or rat kidneys, pieces of cortex, outer, and inner medulla were snap-frozen in TRI reagent (Molecular Research Center, Inc., Cincinnati, OH) and mRNA was isolated according to the manufacturer's directions. cDNA was synthesized by incubating mRNA at 42°C for 1 h with Maloney murine leukemia virus reverse transcriptase (Superscript; Life Technologies, Inc., Gaithersburg, MD), oligo dT (Pharmacia, Piscataway, NJ) as primer, RNAsin (Promega, Madison, WI), dithiothreitol, dNTP (Pharmacia), and bovine serum albumin (Boehringer Mannheim, Indianapolis, IN). The cDNA was precipitated with linear acrylamide as carrier and resuspended in Tris-ethylenediaminetetraacetate (TE) buffer.

For amplification, PCR reactions were performed in a total volume of 50 µl in the presence of 0.1 mM dNTP, 10 mM dithiothreitol, 50 mM KCl, 1.5 mM MgCl2, 10 mM Tris (pH 8.3), and 0.001% gelatin, with 0.5 pmol of each primer, 1.25 U Taq DNA Polymerase (Perkin-Elmer Cetus, Norwalk, CT), 1.5 µCi32P dCTP (Amersham, Arlington Heights, IL), and 1 to 2 µl of tissue cDNA. Mineral oil was layered on top of each sample to prevent evaporation. After an initial denaturation at 94°C for 3.5 min, PCR amplification was performed for 30 cycles at 94°C (denaturation) for 1 min, 54°C (annealing) for 1.5 min, and 72°C (extension) for 1 min, followed by incubation at 72°C for 8 min. To ensure that similar amounts of cDNA template were present between the various samples, we performed semiquantitative PCR on ß-actin-normalized cDNA. ß-actin primers were chosen from the coding region of the human ß-actin sequence (15). From each PCR reaction, the product contained in 45 µl was precipitated with 5% linear acrylamide, 4 M ammonium acetate, and 100% ethanol, resuspended in TE buffer (pH 8.0), and run on a 5% polyacrylamide gel. For ß actin, 10 µl of PCR product was directly loaded onto the polyacrylamide gel. 32P incorporation into bands was detected by autoradiography and quantitated using Phosphor Analyst software on a GS-250 Molecular Imager system (Bio-Rad, Hercules, CA).

Cloning of Mouse ß6 Integrin PCR Products
Briefly, PCR amplification products derived from either mouse or rat cDNA were ligated into the pCR vector (Invitrogen Corp., San Diego, CA), and competent bacteria were transformed with the plasmid. Positive colonies were picked and grown in LB media containing ampicillin. Miniprep DNA (Qiagen, Santa Clarita, CA) from over-night cultures of the clones was sequenced on an ABI 373A autosequencer. Sequences were compared with known sequences by the Blast program of the National Center for Biotechnology Information.

Primer Selection
Initial primers were based on the published human sequence (nt 697 to 880; sense 1, 5' CCG GCT GGC CAA AGA GAT GT; antisense 1, 5' AGT TAA TGG CAA AAT GTG CT (16). The resulting 183-bp product was used to screen a {lambda} gt11 oligo dT-primed library (Clontech Laboratories, Inc., San Diego, CA) from E17 whole mouse. Partial sequence from the 1800-bp insert obtained from screening the {lambda} phage library led to development of new primers that were used for the primary screening of LambdaZap II libraries as described below.

Library Screening/Plaque Hybridization
Initial screening of a {lambda} gt11 phage library from E17 mouse with the 183-bp probe produced one positive plaque. PCR of the plaque DNA using {lambda} forward primer with ß6 antisense primer and {lambda} reverse primer with ß6 sense primer resulted in two products, 800 and 900 bp, respectively. These products were cloned into pCR II, and a partial sequence was obtained. Primers were designed on the basis of this sequence for screening LambdaZap II phagemid libraries (Stratagene, La Jolla, CA) and were as follows: sense 2, 5' AAT AAG CCT CTC AGC GTG GG; antisense 2, 5' AAT TTC GTT GAA CCT CTG GGC ATC; sense 3, 5'GGA CCT CTC CGC CTC CAT GG; antisense 3, 5'ATC CCC CAG CCC CAG AGG CT. The E17 mouse kidney libraries were produced by either oligo dT (designated library A) or random priming (library B). XL1-Blue-MRF' bacteria were incubated with phage (50,000 pfu/plate) at 37°C for 15 min then mixed with top agar, poured onto NZY plates containing ampicillin, and grown for 6 to 8 h. Nylon membranes (Hybond-N, Amersham) were overlaid on each plate, denatured, neutralized, and rinsed in 2X SSC. The bound phage DNA was cross-linked to the filter. The filters were prehybridized in Rapid-Hyb buffer (Amersham) for 30 min at 65°C and hybridized at 65°C with a random-primed 32P-labeled probe (1 x 106 cpm/ml). The filters were washed two times in 2XSSC, 0.1% sodium dodecyl sulfate (SDS) and three times in 0.2XSSC, 0.1% SDS at 65°C. Signal was detected by autoradiography. Positive clones were identified by presence of signal on replicate filters. Positive plaques were placed in SM buffer, titered, and rescreened. In vivo excision was used to obtain positive fragments from the LambdaZap II vector by using ExAssist helper phage and the SOLR strain of cells (Stratagene, La Jolla, CA) generating subclones in the pBluescript SK(-) phagemid. Plasmid DNA was sequenced as described above.

Northern Analysis
Total RNA was isolated from homogenized adult mouse (CD-1) kidney using TriZol reagent (Life Technologies), and poly(A)+ RNA was then prepared using the PolyATract mRNA Isolation System (Promega). RNA was run on a formaldehyde-containing agarose gel and transferred onto a nylon membrane for subsequent hybridization with a random-primed 32P-labeled probe (908 bp; primer pair, S3 and AS3). Filters were washed with 0.1X SSC/0.1% SDS at 60°C. Autoradiography was performed to detect hybridized signal.

In Situ Hybridization and Lectin Histochemistry
For in situ hybridization, both antisense and sense probes were prepared. A plasmid vector containing mouse ß6 integrin sequence (nucleotides 601 to 1508) was used as a template for PCR reactions using primers designed to produce amplification products for the specific RNA polymerase enzyme to be used and either sense or antisense mouse ß6 integrin sequence, without extraneous plasmid sequence. PCR reactions contained either ß6 integrin sense primers, which included primer sequence for T3 polymerase at the 5' end in combination with ß6 integrin-specific antisense primers, or ß6 integrin antisense primers, which included primer sequence for T7 polymerase at the 5' end in combination with ß6 integrin-specific sense primers. The cDNA produced was used as a template for in vitro transcription of cRNA probes. Probes were synthesized with the appropriate T7 or T3 RNA polymerase in the presence of digoxigenin-UTP (DIG RNA labeling mix, Boehringer-Mannheim Biochemicals) and purified with NucTrap columns (Stratagene). The probe was precipitated in the presence of glycogen as carrier and resuspended in the presence of RNase inhibitor. Relative probe concentration was determined by serial dilutions of the probe, followed by dot-blotting the diluted probe on nylon membranes and incubation of the membrane with alkaline-phosphatase—tagged antidigoxigenin antibody. Detection of signal was by incubation with nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate (BCIP). Verification of probe target was performed by dotting 200 ng of appropriate plasmid DNA on a nylon membrane, hybridizing with the riboprobe, and detecting the signal as described for titration of probes. Probes were considered of sufficient concentration if the signal was detected with 10 to 100 pg of probe. Cryosections of whole mouse embryos, embryonic kidneys, or perfused newborn or adult mouse kidneys, mounted on polylysine-treated Probe-On Plus slides (Fisher Scientific, Pittsburgh, PA), were used for in situ hybridization. Hybridization was performed for 16 to 18 h at 65°C. Slides were treated with RNase A to remove nonhybridized probe, and posthybridization washes were performed as follows: 2X SSC at room temperature (RT) for 15 min, 1X SSC at RT for 15 min, 0.5X SSC at 65°C for 60 min, and 0.5X SSC at RT for 15 min. After posthybridization washes, sections were incubated with alkaline phosphatase-conjugated antidigoxigenin antibody (Boehringer Mannheim Biochemicals) and color was developed with nitroblue tetrazolium and BCIP. After optimal color development, coverslips were removed and slides were incubated in TE buffer (pH 7.5) for 5 min. The sections were counterstained with 0.5% methyl green (Siugma Chemical Co., St. Louis, MO), washed in dH2O, dehydrated in graded ethanol, and mounted with Permount (Fisher).

To perform lectin peroxidase co-staining, we performed in situ hybridization on sections as described above, through the point of color development. Slides were then washed in TE buffer and incubated with peroxidase-conjugated lectins (50 µg/ml) in PBS containing Ca2+ and Mg2+ at room temperature for 30 min. Slides were washed three times for 10 min each in PBS without Ca2+ and Mg2+. Diaminobenzidine was used as substrate (Vector Laboratories, Burlingame, CA). Slides were incubated in substrate solution until color developed (2 to 5 min). Slides were then washed in PBS, counter-stained, dehydrated, and coverslipped.

Antisense Oligonucleotide Experiments
Mouse metanephric kidneys isolated at E11.5 were cultured in the presence of phosphorothioated antisense oligonucleotides (AS ODN) to ß6 integrin (n = 13), {alpha}v integrin (n = 10), a nonsense oligonucleotide (NS ODN, n = 10), or Hanks' balanced salt solution (HBSS) as vehicle control (n = 9). Sequences used were as follows: ß6 integrin antisense, 5' TCT CGC CAG CTC CAG ACA GGT GGG TGA AAT T; {alpha}v integrin antisense, 5' GGA CCC GCA TAC TCG GCG GGA CTT TCG ACG TCC AGG TTG AAG G; nonsense, 5' TAA TGA TAG TAA TGA TAG TAA TGA TAG TAA T. The region of the ß6 integrin sequence used for the antisense oligonucleotide sequence was chosen on the basis of its very low homology to other ß integrin molecules, particularly ß1 integrin, which is ubiquitously expressed throughout the kidney. The region was also chosen to be near the 5' end of the molecule to interrupt mRNA processing as much as possible. The {alpha}v AS ODN sequence was used previously by Wada et al. (7) and was shown to inhibit growth and differentiation of cultured mouse E13 metanephric kidneys. The NS ODN was also used in the previous study and was shown to have no effect on the development of metanephric kidneys in culture. Oligonucleotides were added to a final concentration of 1.0 µM. Photomicrographs were obtained at 6 d of culture. Kidneys were detached from the filters and placed in TRI reagent for mRNA isolation and reverse transcription-PCR (RT-PCR) as described.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Nucleotide and Amino Acid Sequences of Mouse ß6 Integrin
Three clones were identified in the two libraries screened, each of which contained a partial sequence for the mouse homologue of ß6 integrin (Figure 1). The complete coding region sequence is shown in Figure 2. The mouse sequence is 82% identical to the human molecule at the nucleotide level. This sequence predicts a 2367 nucleotide open reading frame. The putative amino acid sequence of mouse ß6 integrin is shown in Figure 3 compared with the human sequence. The amino acid sequence has 91.1% similarity and 89.5% identity to the human ß6 integrin, and there is a high degree of similarity to other ß integrin subunits as well. Exceptions to this high similarity are in the regions of the putative signal peptide (approximately residues 6 to 29) and at the end of the cytoplasmic domain, where 5 of the final 10 residues are different. There are 57 conserved cysteines and 9 conserved potential N-glycosylation sites. There are two Arg-Gly-Asp (RGD) sites in the extracellular domain, at residues 514 to 516 and 594 to 596. There are two EGF-like domain cysteine patterns (CxCx5Gx2C) within the extracellular region (residues 479 to 490 and 563 to 574), which are known to be present in other ß integrin chains as well as in a large number of other proteins that are membrane bound (17). This region of EGF is involved in disulfide bond linkages. There are also two cysteine-rich repeat regions often found in integrins, with a similar pattern to the EGF-like repeat pattern (residues 511 to 524 and 591 to 604). These regions are also believed to be involved in disulfide bond formation (16,18). The putative transmembrane region spans residues 708 to 736.



View larger version (10K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 1. Schematic drawing of mouse ß6 integrin cDNA clones and sequencing strategy compared with known human cDNA. Three clones were identified using two LambdaZap II cDNA libraries from E17 mouse kidney (A, oligo dT primed; B, random primed). None of the clones contained full-length sequence. Each clone was sequenced in both forward and reverse direction with at least three different primers. Dashed line indicates untranslated region that was not sequenced.

 


View larger version (100K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 2. Nucleotide sequence of mouse ß6 integrin coding region. Dotted underline ([UNK]) represents putative transmembrane domain. Overlined nucleotides ([UNK]) represent start and stop codons. Boxed region indicates sequence of antisense oligonucleotide. GenBank/EMBL accession number, AF115376.

 


View larger version (62K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 3. Deduced amino acid sequence of mouse ß6 integrin aligned with human sequence. Bottom line shows regions of consensus (dashes indicate difference). The mouse peptide sequence has 89.5% identity and 91.1% similarity to the human sequence. Underline represents transmembrane region (residues 708 to 736). Potential N-glycosylation sites are overlined. Asterisks (*) mark conserved cysteines.

 

Northern Analysis of Adult Mouse Kidney mRNA
The mouse ß6 integrin transcript is approximately 4.5 to 4.8 Kb as determined from Northern analysis of adult mouse mRNA (Figure 4). The human ß6 integrin mRNA transcript is reported to be approximately 5 Kb (16).



View larger version (32K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 4. Northern analysis of adult mouse kidney mRNA for the ß6 integrin transcript. Total kidney RNA was harvested from adult mouse kidneys and transferred to nitrocellulose membranes. Membranes were probed with a 32P-labeled 908-bp PCR fragment of mouse ß6 integrin representing nucleotides 600 to 1508. Autoradiography demonstrates a transcript of approximately 4.5 Kb. Position of size marker bands indicated at right.

 

Expression of ß6 Integrin mRNA in the Developing and Adult Mouse Kidney and In Microdissected Rat Nephron Segments by RT-PCR
ß6 integrin mRNA expression is present at 11.5 d of gestation (E11), which is the initial point of metanephric kidney formation in the mouse (Figure 5A). The expression remains low at 14 d of gestation (E14) but is increased at 17 d of gestation (E17) and again shortly after birth (PND4 and PND7). Expression declines as the kidney matures (AD). Filter culture of metanephric kidneys provides a reasonable model system for the study of ß6 integrin in the developing mouse kidney as expression was increased in cultured explants and peaked after approximately 5 d (Figure 5B), a time point when the morphology of the cultured kidneys is similar to that seen in late gestation and the early postnatal period. Adult rat and mouse kidneys showed the same overall pattern of expression: approximately equal cortical and medullary ß6 integrin mRNA expression (data not shown). Microdissected nephron segments from adult rat kidney (Figure 6) demonstrated ß6 integrin mRNA expression predominantly in PCT, in medullary thick ascending limb and medullary and cortical collecting duct segments, and to a lesser degree in macula densa—containing segments.



View larger version (36K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 5. ß6 integrin mRNA expression in developing and cultured mouse metanephric kidneys. (A) Expression in developing mouse kidneys. By reverse transcription-PCR (RT-PCR), ß6 integrin mRNA expression was present as early as E11 and E14 in mouse kidneys. Expression increased at E17 and was greatest at 4 and 7 d after birth (PND4 and PND7). Expression at 7 wk of age (AD) was decreased compared with late gestation and the early postnatal period. cDNA was normalized for ß-actin expression (10- and 100-fold dilution of cDNA for ß-actin PCR, stock and 1:10 dilution of cDNA was used for ß6 integrin PCR). (B) Expression in cultured mouse metanephric kidneys. By RT-PCR, ß6 integrin mRNA expression was increased after 2 and 5 d in culture (C2 and C5), following a pattern similar to E11 to E17 time points. Expression was induced 15- to 20-fold after 5 d in culture. 1X indicates that stock cDNA was used for PCR, 10X and 100X indicate cDNA was diluted 1:10 or 1:100 before PCR was performed. All cDNA samples were normalized for ß actin.

 


View larger version (20K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 6. ß6 integrin mRNA expression in adult rat nephron segments. RT-PCR for ß6 integrin and ß actin mRNA in various nephron segments. ß6 integrin mRNA is expressed primarily in proximal convoluted tubule (PCT), macula densa—containing segments (MDCS), cortical thick ascending limb (cTAL), cortical collecting duct (CCD), outer medullary collecting duct (OMCD), and inner medullary collecting duct (IMCD). ß6 integrin mRNA expression was not detected in glomeruli. GLOM, glomerulus without vascular or tubular attachments; mTAL, medullary thick ascending limb of Henle's loop. Each cDNA was used straight or diluted 1:10 for the ß6 integrin PCR and diluted 1:10 and 1:100 for the ß-actin PCR. Representative of seven separate nephron dissection preparations for each segment.

 

Expression of ß6 Integrin mRNA in the Developing Mouse Kidney by In Situ Hybridization and Colocalization with Lectins
Figures 7 and 8 demonstrate expression of ß6 integrin mRNA in E17 mouse kidneys. ß6 integrin is highly expressed in the developing PCT and loop of Henle (H). The expression overlaps with that of the lectin Lotus tetragonolobus (Figure 8, C and D), which recognizes cells of the PCT in embryonic mouse kidney (19). Expression of ß6 integrin is also found in other developing tubule segments, including the distal convoluted tubule (DCT; Figure 7F). In developing macula densa segments, there is no expression of ß6 integrin mRNA (comma- and s-shaped body stages; Figure 7, C and D). In occasional glomeruli, which are more mature (G), a faint juxtaglomerular signal can be identified. This pattern of expression differs from that reported in primate kidneys (16), which was described specifically as macula densa expression, with little expression elsewhere. Figure 8 demonstrates that there is no expression of ß6 integrin in the collecting ducts at 17 d of gestation, as evidenced by a lack of overlap of the in situ signal with the signal for the lectin Dolichos biflorus (Figure 8, A and B).



View larger version (161K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 7. ß6 integrin mRNA expression in E17 mouse kidneys demonstrated by RNA in situ hybridization using digoxigenin-labeled riboprobes. Methyl green counterstain. (A) Sense probe. (B through F) Antisense probe. (B) ß6 integrin mRNA expression (dark blue) is primarily in juxtamedullary cortex and medulla. The superficial cortical nephrogenic zone has little ß6 integrin mRNA expression at E17 (*). (C through F) ß6 integrin mRNA is expressed strongly in PCT segments and loop of Henle (H). There is a lower level of expression in distal convoluted tubule segments (DCT). There is ß6 integrin expression adjacent to some capillary-stage glomeruli (G), possibly in macula densa. There is no expression at E17 in comma (C)- and S-shaped (S) bodies, in undifferentiated mesenchyme (M), or within capillary-stage glomeruli. Magnifications: x60 in A; x40 in B; x200 in C and D; x400 in E and F.

 


View larger version (100K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 8. Combined ß6 integrin RNA in situ hybridization and lectin-peroxidase staining in E17 mouse kidneys. (A and B) Dolichos biflorus lectin-peroxidase conjugate (brown) identifies developing collecting system. ß6 integrin mRNA expression demonstrated by in situ signal (dark blue) in developing tubule segments, including proximal tubule and loop of Henle. Note lack of overlap of two signals demonstrating lack of ß6 integrin mRNA in developing ureteric bud/collecting duct segments. (C and D) Co-labeling with Lotus tetragonolobus-peroxidase conjugate (PCT) reveals overlap of peroxidase stain and in situ signals, demonstrating ß6 integrin mRNA expression in PCT. Lack of overlap occurs in some PCT segments (peroxidase stain alone), and in other segments with ß6 integrin in situ signal only possibly representing loop of Henle and some portions of the DCT. Magnifications: x200 in A through C; x400 in D.

 

Effect of Antisense Oligonucleotides on Metanephric Kidney Development
Mouse E11.5 kidneys cultured in the presence of a nonsense oligonucleotide (Figure 9B) or HBSS as vehicle control (Figure 9A) demonstrated normal branching of the ureteric bud with development of comma- and s-shaped bodies by 6 d in culture. As shown previously by Wada et al. (7), incubation with an antisense oligonucleotide to the {alpha}v subunit (Figure 9C) resulted in disruption of normal ureteric bud branching and nephron formation. Similarly, incubation with an antisense oligonucleotide to ß6 integrin (Figure 9D) inhibited branching of the ureteric bud, condensation of the mesenchyme, and conversion of mesenchyme cells to epithelial cells. RT-PCR studies (Figure 10) demonstrated a highly reduced expression of ß6 integrin mRNA in kidneys cultured in the presence of the ß6 integrin ODN but not in the presence of the nonsense or {alpha}v antisense oligonucleotides.



View larger version (146K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 9. Effect of antisense and nonsense oligonucleotides on cultured mouse metanephric kidney development. (A) Control (no oligonucleotide, Hanks' balanced salt solution vehicle control) E11 metanephric kidney after 6 d in filter culture. The ureteric bud (*) has branched extensively, and there are numerous developing glomerular and tubular structures present. S-shaped bodies ([UNK]) can be identified. (B) Nonsense oligonucleotide. An oligonucleotide composed of stop codons had no effect on development of metanephric kidneys in culture. (C) Antisense oligonucleotide to {alpha}v integrin subunit. There is minimal branching of the ureteric bud and reduced differentiation of the mesenchyme. (D) Antisense oligonucleotide to ß6 integrin subunit. There is no branching of the ureteric bud beyond the initial split present at isolation. No condensation or differentiation of the mesenchyme occurred. Magnification, x33.

 


View larger version (48K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 10. ß6 integrin mRNA expression in cultured metanephric kidneys treated with antisense oligonucleotides. RT-PCR for ß6 integrin was performed on mRNA isolated from E11 metanephric kidneys that had been cultured for 6 d in the presence of antisense oligonucleotides (ODN) to ß6 integrin (B6 ODN), {alpha}v integrin ({alpha}v ODN), or a nonsense oligonucleotide (NS ODN). Control preparations (CON) included equivalent amounts of vehicle without oligonucleotide. ß6 integrin mRNA expression was reduced in two preparations treated with B6 ODN but was unaffected by the {alpha}v or nonsense ODN.

 


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Integrins and their interaction with the extracellular matrix are vital for the development, growth, and differentiation of organs (20). In the kidney, a model of reciprocal epithelial—mesenchymal interaction, where changing extracellular matrix components have been linked to the phase of development (21), integrins certainly play an important but poorly studied role in nephrogenesis. The conversion of the metanephric mesenchyme to epithelial cells involves a complex rearrangement of extracellular protein expression; there is a loss of interstitial-type extracellular matrix molecules such as collagen types I and III and the appearance of basement membrane—type proteins such as collagen type IV, laminin, and proteoglycans (21). Presumably, changes in extracellular matrix components are paralleled by changes in their receptors, the integrins. One integrin molecule that was recently demonstrated to be important for proper development of the nephron is the {alpha}v integrin, a promiscuous integrin that associates with several ß subunits, including ß1, ß3, ß5, ß6, and ß8. Wada et al. (7) showed that antibodies to the {alpha}v subunit or antisense oligos result in abnormal nephrogenesis when applied to cultured metanephric kidneys. Studies by Kreidberg et al. (3) suggest a role for the {alpha}3ß1 integrin in kidney development as well. Mice that are heterozygous for mutation of the {alpha}3 integrin gene demonstrate abnormal branching morphogenesis and poor glomerular basement membrane formation.

The ß6 integrin, which associates solely with the {alpha}v subunit to form a fibronectin and tenascin receptor (9,10,11), was described previously to be expressed very specifically in the macula densa of primate kidneys and to show greater expression during gestation than in the mature kidney, suggesting a role in the development of the kidney, particularly the macula densa. Later studies demonstrated enhanced expression of this subunit in the kidney during inflammation, such as in chronic rejection, and in other tissues after injury, suggesting a role for ß6 integrin in inflammation and repair (8).

Despite the relative lack of expression in the macula densa of the mouse, ß6 integrin is expressed in high levels in several other segments of the nephron. The expression of ß6 integrin in the loop of Henle during development may suggest that this integrin subunit plays a role in proper development of the loop structure of the nephron. This is supported by the findings that antisense oligonucleotides to ß6 integrin severely disrupt the normal development of the metanephric kidney. The ureteric bud did not branch and there was no condensation of the mesenchyme around the tips of the ureteric bud. Subsequently, there was no formation of comma- and S-shaped bodies. A nonsense oligonucleotide had no effect, whereas an antisense oligonucleotide to {alpha}v integrin, which was shown previously to interfere with metanephric development (7), produced similar results to the ß6 integrin antisense oligonucleotide. The results achieved in the present experiments with the {alpha}v integrin antisense oligonucleotide were more dramatic than had been published by Wada et al. (7), most likely because of the difference in gestational age at time of isolation of the kidneys. The previous study isolated the kidneys at E13, when some ureteric bud branching and nephron development has already occurred. In the present study, the kidneys were isolated at E11.5, a time point when the ureteric bud has just entered the mesenchyme. The dramatic effect of the ß6 integrin antisense oligonucleotide demonstrates the importance of this molecule in the epithelial—mesenchymal interaction during normal development of the mouse metanephric kidney. How these findings relate to the lack of a kidney phenotype in the ß6 integrin knockout mouse (13) is unclear. However, as suggested by Sariola (22), the kidney likely has redundant mechanisms for many important molecules, and because the {alpha}v subunit has several ß subunit binding partners and many of these, including the uniquitous ß1 integrin, are expressed in the kidney, the loss of ß6 integrin in the knockout may be made up by association of {alpha}v with one of its other binding partners. Because the in vitro metanephric kidney culture does not fully recapitulate the environment of the whole embryo, these same compensatory mechanisms may not be available in the tissue culture setting. Recruitment of redundant molecules likely requires input from surrounding tissues and cells, neurologic input, and the vasculature, all of which are absent in the tissue culture system.

The results from the present study differ from the original report in primate tissues, which described highly localized ß6 integrin expression in the macula densa (12), particularly in the developing kidney, with no expression in other segments except when there is inflammation in the kidney (8). In the mouse and rat, ß6 integrin is expressed in many nephron segments in both the embryonic and the mature kidney. There is expression mainly in the PCT, thick ascending limb of Henle, and the outer medullary and cortical collecting ducts. There is expression in the macula densa after the glomerulus becomes mature. The discrepancies between our results and the previous study may be due to species differences. Given this difference in ß6 integrin expression between primate and rodent tissues, the full nucleotide sequence of the coding region described in the present study should provide useful information for investigators who study integrins and the extracellular matrix in rodent tissue. This is particularly relevant for investigators in the field of kidney development, where many of the previous studies were and current research is performed with rat or mouse tissue.

In summary, this study demonstrates that mouse ß6 integrin is similar to the primate molecule; it is expressed in the developing and mature mouse kidney, and in the cultured metanephric kidney setting the lack of ß6 integrin expression has dramatic effects on renal development.


    Acknowledgments
 
This research was supported by NIH grants NRSA-DK09325 (L.J.A.), K08-DK02515 (L.J.A.), R01-DK40042 (J.P.B.), and the Amgen Young Investigator Grant of the National Kidney Foundation (L.J.A.).


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Ruoslahti E: Integrins. J Clin Invest87 : 1-5,1991
  2. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11 -25, 1992[Medline]
  3. Kreidberg JA, Donovan MJ, Goldstein SL, Rennke H, Shepherd K, Jones RC, Jaenisch R: Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Development 122:3537 -3547, 1996[Abstract]
  4. Yang JT, Rayburn H, Hynes RO: Embryonic mesodermal defects in {alpha}5 integrin-deficient mice. Development 119:1093 -1105, 1993[Abstract]
  5. Yang JT, Rayburn H, Hynes RO: Cell adhesion events mediated by {alpha}4 integrins are essential in placental and cardiac development. Development. 121:549 -560, 1995[Abstract]
  6. Müller U, Sang D, Denda S, Meneses J, Pedersen R, Reichardt L: Integrin {alpha}8ß1 is critically important for epithelial-mesenchymal interactions during kidney morphogenesis. Cell 88:603 -613, 1997[Medline]
  7. Wada J, Kumar A, Liu Z, Ruoslahti E, Reichardt L, Marvaldi J, Kanwar YS: Cloning of mouse integrin {alpha}v cDNA and role of the {alpha}v-related matrix receptors in metanephric development. J Cell Biol 132:1161 -1176, 1996[Abstract/Free Full Text]
  8. Breuss JM, Gallo J, DeLisser HM, Klimanskaya IV, Folkesson HG, Pittet JF, Nishimura SL, Aldape K, Landers DV, Carpenter W, Gillett N, Sheppard D, Matthay MA, Albelda SM, Kramer RH, Pytela R: Expression of the ß6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Science 108:2241 -2251, 1995[Abstract]
  9. Busk M, Pytela R, Sheppard D: Characterization of the integrin ß6 as a fibronectin-binding protein. J Biol Chem 267:5790 -5796, 1992[Abstract/Free Full Text]
  10. Prieto AL, Edelman GM, Crossin KL: Multiple integrins mediate cell attachment to cytotactin/tenascin. Proc Natl Acad Sci USA 90:10154 -10158, 1993[Abstract/Free Full Text]
  11. Weinacker A, Chen A, Agrez M, Cone R, Nishimura S, Wayner E, Pytela R, Sheppard D: Role of the integrin {alpha}vß6 in cell attachment to fibronectin: Heterologous expression of intact and secreted forms of the receptor. J Biol Chem269 : 6940-6948,1994[Abstract/Free Full Text]
  12. Breuss JM, Gillett N, Lu L, Sheppard D, Pytela R: Restricted distribution of integrin ß6 mRNA in primate epithelial tissues. J Histochem Cytochem41 : 1521-1527,1993[Abstract]
  13. Huang X, Wu J, Cass D, Erle DJ, Corry D, Young SG, Farese RV, Sheppard D: Inactivation of the integrin ß6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lungs and skin. J Cell Biol 133:921 -928, 1996[Abstract/Free Full Text]
  14. Grobstein C: Some transmission characteristics of the tubule-inducing influence on mouse metanephrogenic mesenchyme. Exp Cell Res 10:424 -440, 1956[Medline]
  15. Gunning P, Ponte P, Okayama H, Engel J, Blau H, Kedes L: Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: Skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol Cell Biol3 : 787-795,1983[Abstract/Free Full Text]
  16. Sheppard D, Rozzo C, Starr L, Quaranta V, Erle DJ, Pytela R: Complete amino acid sequence of a novel integrin ß subunit (ß6) identified in epithelial cells using the polymerase chain reaction. J Biol Chem 265:11502 -11507, 1990[Abstract/Free Full Text]
  17. Tamkun JW, DeSimone DW, Fonda D, Patel RS, Buck C, Horwitz AF, Hynes RO: Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin. Cell46 : 271-282,1986[Medline]
  18. Moyle M, Napier MA, McLean JW: Cloning and expression of a divergent integrin subunit beta 8. J Biol Chem266 : 19650-19658,1991[Abstract/Free Full Text]
  19. Laitinen L, Virtanen I, Saxen L: Changes in the glycosylation pattern during embryonic development of mouse kidney as revealed with lectin conjugates. J Histochem Cytochem35 : 55-65,1987[Abstract]
  20. Adams JC, Watt FM: Regulation of development and differentiation by the extracellular matrix. Development117 : 1183-1198,1993[Medline]
  21. Ekblom P: Determination and differentiation of the nephron. Med Biol 59:139 -160, 1981[Medline]
  22. Sariola H: Does the kidney express redundant or important molecules during nephrogenesis? Exp Nephrol 4:70 -76, 1996[Medline]
Received for publication October 5, 1999. Accepted for publication May 8, 2000.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
K. Hahm, M. E. Lukashev, Y. Luo, W. J. Yang, B. M. Dolinski, P. H. Weinreb, K. J. Simon, L. Chun Wang, D. R. Leone, R. R. Lobb, et al.
{alpha}v{beta}6 Integrin Regulates Renal Fibrosis and Inflammation in Alport Mouse
Am. J. Pathol., January 1, 2007; 170(1): 110 - 125.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. H. Weinreb, K. J. Simon, P. Rayhorn, W. J. Yang, D. R. Leone, B. M. Dolinski, B. R. Pearse, Y. Yokota, H. Kawakatsu, A. Atakilit, et al.
Function-blocking Integrin {alpha}v{beta}6 Monoclonal Antibodies: DISTINCT LIGAND-MIMETIC AND NONLIGAND-MIMETIC CLASSES
J. Biol. Chem., April 23, 2004; 279(17): 17875 - 17887.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L.-J. Ma, H. Yang, A. Gaspert, G. Carlesso, M. M. Barty, J. M. Davidson, D. Sheppard, and A. B. Fogo
Transforming Growth Factor-{beta}-Dependent and -Independent Pathways of Induction of Tubulointerstitial Fibrosis in {beta}6-/- Mice
Am. J. Pathol., October 1, 2003; 163(4): 1261 - 1273.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by AREND, L. J.
Right arrow Articles by BRIGGS, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by AREND, L. J.
Right arrow Articles by BRIGGS, J. P.


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP